Predictors of cancer on repeat prostate biopsy: A contemporary UK series

References 

1. Prostate cancer. NICE full guideline; February 2008.
2. Cancer Research UK; 2007. Available from www.cancerresearchuk.org.
3. National Cancer Care Network guidelines, v.1; 2007.
4. Djavan B, Zlotta A, Remzi M, Ghawidel K, Bashharkhan A, Schulman CC, et al. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol. 2000;163:1144–1149
   • Abstract
   • Full Text
   • Full-Text PDF (265 KB)
   • CrossRef
5. Prostate Cancer Risk Management Programme. Department of Health; 2006.
6. De la Taille , Jones JS, Klein EA. The motion: at least 18 cores are necessary to make a prostatic biopsy useful. Eur Urol. 2008;53:659–662
   • Full Text
   • Full-Text PDF (213 KB)
   • CrossRef
7. Ravery V, Dominique S, Panhard X, Toublanc M, Boccon-Gibod L, Boccon-Gibod L. The 20-core prostate biopsy protocol—a new gold standard?. J Urol. 2008;179:504–507
   • Full-Text PDF (177 KB)
   • CrossRef
8. Sieber PR, Rommel FM, Theodoran CG, Hong RD, Del Terzo MA. Contemporary prostate biopsy complication rates in community-based urology practice. Urology. 2007;70:498–500
   • Abstract
   • Full Text
   • Full-Text PDF (62 KB)
   • CrossRef
9. Neill MG, Toi A, Lockwood GA, Evans A, Lisa Tammsalu L, Fleshner NE. Systematic lateral prostate biopsy—are the benefits worth the costs?. J Urol. 2008;179:1321–1326
   • Abstract
   • Full Text
   • Full-Text PDF (388 KB)
   • CrossRef
10. Durkan GC, Greene DR. Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: who should undergo a repeat biopsy?. BJU Int. 1999;83(1):34–38
    • MEDLINE
    • CrossRef